QIAGEN N.V. today announced details for completion of the synthetic share repurchase plan to return up to approximately $300 million that combines a direct capital repayment to QIAGEN shareholders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback